Skip to main content
Cachet Pharmaceutical Co., Ltd. logo

Cachet Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 002462 ISIN · CNE100000SN0 LEI · 300300CBONJS7HUOCX64 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,441 across all filing types
Latest filing 2013-12-02 Audit Report / Informat…
Country CN China
Listing Shenzhen Stock Exchange 002462

About Cachet Pharmaceutical Co., Ltd.

https://www.cachet.com.cn

Cachet Pharmaceutical Co., Ltd. specializes in the distribution and retail of pharmaceutical products and medical devices. The company operates an extensive wholesale network and a chain of retail pharmacies, providing comprehensive supply chain solutions to healthcare institutions and end-consumers. Its core operations include the procurement, storage, and logistics of western medicines, traditional Chinese medicines, and high-value medical consumables. Cachet Pharmaceutical emphasizes modern logistics management and professional pharmaceutical services, leveraging a robust distribution infrastructure to ensure the efficient delivery of healthcare products. The company also focuses on hospital supply chain integration and community-based retail services to enhance healthcare accessibility.

Recent filings

Filing Released Lang Actions
北京爱瑞格恩经贸有限公司审计报告及财务报表（2013年1月1日至2013年10月31日止）
Audit Report / Information Classification · 95% confidence The document is titled as an audit report and financial statements for the period from January 1, 2013 to October 31, 2013. It contains an auditor's opinion, detailed financial statements including balance sheet and income statement, and extensive notes on accounting policies and company background. The presence of an auditor's report with an opinion on the financial statements and detailed financial data confirms this is a standalone audit report. It is not a full annual report (10-K) because it covers a partial period (less than a full fiscal year) and is specifically labeled as an audit report. It is not a regulatory filing or announcement since it contains substantive financial data and analysis. Therefore, the document fits the category of Audit Report / Information (AR). 9M 2013
2013-12-02 Chinese
关于股东减持股份的提示性公告
Major Shareholding Notification Classification · 100% confidence The document is a notification about a shareholder reducing their shareholding in the company 嘉事堂药业股份有限公司. It details the number of shares sold, dates, prices, and the shareholder's holdings before and after the reduction. It explicitly mentions it is a "提示性公告" (a prompt or indicative announcement) regarding shareholder reduction. There is no financial data, no report attached or referenced as being published, and no mention of management changes or legal proceedings. This fits the definition of a Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels crossing thresholds.
2013-11-22 Chinese
简式权益变动报告书
Major Shareholding Notification Classification · 100% confidence The document is titled as a "简式权益变动报告书" which translates to a "Simplified Equity Change Report." It details the reduction in shareholding by the China Youth Development Foundation in Jia Shi Tang Pharmaceutical Co., Ltd. It includes specifics about share quantities, percentages before and after the change, dates of transactions, and regulatory references to securities law and disclosure requirements. The content focuses on the disclosure of changes in significant share ownership levels, including the method and purpose of the share reduction. There is no indication of financial statements, audit information, management discussion, or other report types. This matches the definition of a Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels crossing thresholds. The document length and detail confirm it is the report itself, not just an announcement or certification, so it is not RPA or RNS.
2013-11-22 Chinese
关于召开2013年第二次临时股东大会的通知公告
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a notice announcing the convening of the company's 2013 second extraordinary general meeting of shareholders, including details about the meeting date, location, agenda, and registration procedures. It does not contain any financial statements, results, or detailed reports but serves as an official announcement to shareholders about the meeting. The document length is short (1985 characters), and it primarily provides meeting logistics and agenda items, which fits the profile of a Proxy Solicitation & Information Statement (PSI) or a meeting notice. Since it includes an authorization proxy form for voting, it aligns best with Proxy Solicitation & Information Statement (PSI).
2013-11-14 Chinese
关于授权管理层出售公司持有的中青旅股份议案的独立董事意见
Regulatory Filings Classification · 95% confidence The document is a formal announcement from 嘉事堂药业股份有限公司 regarding the independent directors' opinion on authorizing management to sell shares held in another company. It references corporate governance guidelines and the company's articles of association. The content is about a management authorization proposal related to share disposal, not a financial report, earnings release, or meeting materials. It is not a report itself but an official announcement of a corporate governance matter requiring shareholder approval. The document length is short (708 characters), and it does not contain financial statements or detailed financial data. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2013-11-14 Chinese
出售可供出售金融资产暨复牌的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement by 嘉事堂药业股份有限公司 regarding the sale of available-for-sale financial assets and the resumption of trading of its stock. It details the board's authorization to sell shares, the purpose of the sale, risk warnings, and the resumption of stock trading. The document is relatively short (2003 characters) and does not contain financial statements or detailed financial analysis. It is an announcement about a capital transaction and stock resumption rather than a full financial report or earnings release. The content fits best under Capital/Financing Update (CAP) as it relates to the company's financing activities and capital structure changes through the sale of financial assets and stock resumption.
2013-11-14 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.